Natco Pharma Ltd EPS

Natco Pharma Ltd EPS

Image

Natco Pharma Ltd

NSE: NATCOPHARM

EPS

₹ 79.2

Last updated on: Jul 27, 2026

Key Highlights

  • The Earning per Share of Natco Pharma Ltd is ₹ 79.2 as of 27 Jul 26 The earning per share of Natco Pharma Ltd changed from ₹ 37.32 to ₹ 14.96 over 8 quarters. This represents a CAGR of -36.69% .

Historical Earning per Share of Natco Pharma Ltd

No data available

* All values are in

Company Fundamentals for Natco Pharma Ltd

Market Cap

16,606 Cr

EPS

79.2

P/E Ratio (TTM)

11.7

P/B Ratio (TTM)

1.8

Day’s High

934.85

Day’s Low

920.4

DTE

0.1

ROE

15.4

52 Week High

1226.1

52 Week Low

789.3

ROCE

15.4

Market Price of Natco Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Natco Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
27 Jul 2026927.15
24 Jul 2026920.8
23 Jul 2026918.85
22 Jul 2026934.8
21 Jul 2026961.95
20 Jul 2026950.55
17 Jul 2026945.75
16 Jul 2026965.75
15 Jul 2026969.75
14 Jul 2026971.85

SWOT Analysis Of Natco Pharma Ltd

Strength

4

che

Weakness

3

che

Opportunity

1

che

Threats

1

che

BlinkX Score for Natco Pharma Ltd

Asset Value vs Market Value of Natco Pharma Ltd

Market Value

16,492

Asset Value

Value addition

2.1 X

5,245

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Natco Pharma Ltd16606
Sun Pharmaceutical Industries Ltd473509
Divis Laboratories Ltd196881
Torrent Pharmaceuticals Ltd190832
Cipla Ltd113894
Zydus Lifesciences Ltd110523

Historical Market Cap of Natco Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Natco Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Natco Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Natco Pharma Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Natco Pharma Ltd News Hub

Natco Pharma invests USD 8 mn in bio-tech firm eGenesis

Natco Pharma announced that its wholly owned Canadian subsidiary, Natco Pharma (Canada) Inc. has mad

Read more

04 Sept 24

Natco Pharma fixes record date for second interim dividend

Natco Pharma has fixed 23 August 2024 as record date for second interim dividend for FY 2024-25. The

Read more

12 Aug 24

Board of Natco Pharma recommends dividend

Natco Pharma announced that the Board of Directors of the Company at its meeting held on 12 August 2

Read more

12 Aug 24

Natco Pharma schedules AGM

Natco Pharma announced that the 41th Annual General Meeting (AGM) of the company will be held on 30

Read more

12 Aug 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

June 2024

TranscriptPPT

May 2024

PPT

June 2023

TranscriptPPT

June 2022

TranscriptPPT

FAQs for EPS of Natco Pharma Ltd

What is the EPS of Natco Pharma Ltd stock?

The Earnings Per Share (EPS) of Natco Pharma Ltd is 79.2. An EPS is the amount of net income attributed to each share of a common stock.

How is Natco Pharma Ltd EPS calculated?

The EPS of Natco Pharma Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Natco Pharma Ltd report its EPS?

Natco Pharma Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Natco Pharma Ltd EPS?

Factors that influence the EPS of Natco Pharma Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Natco Pharma Ltd EPS growth indicate future performance?

Yes, consistent growth in Natco Pharma Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions